Skip to main content

Milos Raonic of Canada plays a backhand in his Wimbledon match against Nick Kyrgios earlier this month.

Clive Brunskill/Getty Images

Canada's Davis Cup tennis team will be without its top-ranked player when it faces Belgium in quarter-final action next week.

Tennis Canada said in a release Tuesday that world No. 8 Milos Raonic will miss the quarter-final tie due to lingering effects from foot surgery he had before the French Open.

"I'm devastated not to be participating in this tie against Belgium," Raonic, from Thornhill, Ont., said in the release. "Due to my recurring injury, I am not able to play tennis for the next few weeks. My goal right now is to get healthy as fast as possible and get back to playing tennis as soon as I can.

Story continues below advertisement

"I have been with this team awhile and we have come a long way together. I know that they can win this tie and get us back into the semifinals."

Raonic was eliminated in the third round at Wimbledon by Australia's Nick Kyrgios.

Canada will have Vancouver's Vasek Pospisil available for the best-of-five series, which is being held on a clay court in Ostend, Belgium from July 17-19.

Pospisil is currently playing well at Wimbledon, where he has advanced to the quarter-finals.

Davis Cup veteran Frank Dancevic of Niagara Falls, Ont., doubles ace Daniel Nestor of Toronto and Vancouver's Filip Peliwo, who will make his Davis Cup debut, were also named to the squad by captain Martin Laurendeau.

Toronto's Adil Shamasdin was named to the team as an alternate.

Belgium is led by world No. 15 David Goffin, who will be joined by Steve Darcis, Ruben Bemelmans and Kimmer Coppejans.

Story continues below advertisement

Canada defeated Japan 3-2 in Vancouver in March to set up the quarter-final with Belgium.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter